# Donanemab Shows Promise for Alzheimer's | Perth News Page: https://stenobird.com/podcast/perth-news-today-2-min-news-the-daily-news-now-7574199/donanemab-shows-promise-for-alzheimer-s-perth-news Text version: https://stenobird.com/podcast/perth-news-today-2-min-news-the-daily-news-now-7574199/donanemab-shows-promise-for-alzheimer-s-perth-news.md Podcast: [Perth News Today | 2 Min News | The Daily News Now!](https://stenobird.com/podcast/perth-news-today-2-min-news-the-daily-news-now-7574199) Published: 2026-07-17T09:06:31+00:00 Episode link: https://sources.thednn.ai/faa36404c0f32c36 Audio file: https://api.fastcast.ai/audio/4cbee219-6855-400f-a839-fefba0cd3a8c.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/perth-news-today-2-min-news-the-daily-news-now-7574199/episodes/donanemab-shows-promise-for-alzheimer-s-perth-news Duration seconds: 106 ## Resource A breakthrough Alzheimer’s drug called donanemab is showing real promise, slowing cognitive decline for up to three years in early-stage patients—some even after treatment ends. In a major study of 1,200 people, those receiving the IV drug saw significantly slower mental decline, with amyloid plaques slashed by 90% and tau markers reduced. But caution is needed: rare but serious side effects like brain swelling and bleeding have occurred, including deaths. Though licensed, it’s not yet on the NHS due to cost concerns, and widespread rollout faces systemic hurdles as dementia cases surge. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/faa36404c0f32c36 ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/perth-news-today-2-min-news-the-daily-news-now-7574199/episodes/donanemab-shows-promise-for-alzheimer-s-perth-news/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/perth-news-today-2-min-news-the-daily-news-now-7574199/donanemab-shows-promise-for-alzheimer-s-perth-news.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.